Planar gamma scintigraphy - Points to consider when quantifying pulmonary dry powder aerosol deposition

International Journal of Pharmaceutics

Volumn 251, Issue 1-2, 2003, Pages 33-47

  Bondesson, Eva ^a,b   Bengtsson, Thomas ^a   Borgström, Lars ^a   Nilsson, Lars Erik ^b   Norrgren, Kristina ^b   Trofast, Eva ^a   Wollmer, Per ^b  

^a ASTRAZENECA R AND D   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Administration; Inhalation; Powder inhaler; Radioactive aerosol; Radionuclide imaging; Technetium 99m

Indexed keywords

LACTOSE; SALBUTAMOL SULFATE; TECHNETIUM 99M;

ADULT; AEROSOL; AGED; ARTICLE; CHEMICAL LABELING; CONTROLLED STUDY; DRUG LABELING; DRY POWDER; GAMMA RADIATION; GAMMA SCINTIGRAPHY; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; ISOTOPE LABELING; LUNG DEPOSIT; MALE; NORMAL HUMAN; POWDER INHALER; PRIORITY JOURNAL; QUALITY CONTROL; QUANTITATIVE ANALYSIS; VALIDATION PROCESS;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; AEROSOLS; AGED; ALBUTEROL; ANALYSIS OF VARIANCE; CONFIDENCE INTERVALS; HUMANS; INJECTIONS, INTRAVENOUS; LUNG; MALE; MIDDLE AGED; POWDERS; RADIONUCLIDE IMAGING; TECHNETIUM;

EID: 0037472357     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(02)00579-3     Document Type: Article

References (22)

1. Arborelius M., Miörner G., Lindell S.E., Svanberg L., Swenson E.W. Four quadrant radiospirometry in normal and diseased states. Gilson A.J., Smoak W.M. Pulmonary investigation with radionuclides. 1970;216-226 Thomas, Springfield, Illinois.
2. Berglund E., Birath G., Bjure J., Grimby G., Kjellmer I., Sandqvist L., Söderholm B. Spirometric studies in normal subjects. I Forced expirograms in subjects between 7 and 70 years of age. Acta Med. Scand. 173:1963;185-192.
3. 11C]triamcinolone acetonide. J. Nucl. Med. 41:2000;1603-1611.
4. Bondesson E., Asking L., Borgström L., Nilsson L.-E., Trofast E., Wollmer P. In vitro and in vivo aspects of quantifying intrapulmonary deposition of a dry powder radioaerosol. Int. J. Pharm. 232:2002;149-156.
5. Borgström L., Nilsson M. A method for determination of the absolute pulmonary bioavailability of inhaled drugs: terbutaline. Pharm. Res. 7:1990;1069-1070.
6. Borgström L., Newman S., Weisz A., Morén F. Pulmonary deposition of inhaled terbutaline: comparison of scanning gamma camera and urinary excretion methods. J. Pharm. Sci. 81:1992;753-755.
7. European Pharmacopoeia Third Ed., 1997. Section 2.9.18, pp. 143-150.
8. Evans M.E., Walker S.R., Brittain R.T., Paterson J.W. The metabolism of salbutamol in man. Xenobiotica. 3:1973;113-120.
9. Fanti S., Compagnone G., Pancaldi D., Franchi R., Corbelli C., Marengo M., Onofri C., Galassi R., Levorato M., Monetti N. Evaluation of lung clearance of inhaled pertechnegas. Ann. Nucl. Med. 10:1996;147-151.
10. Köhler D., Fleischer W., Matthys H. New method for easy labelling of beta-2-agonists in the metered dose inhaler with technetium 99m. Respiration. 53:1988;65-73.
11. 2 sympathomimetics terbutaline, salbutamol and fenoterol. Preliminary results. J. Chromatogr. 229:1982;217-221.
12. Macey D.J., Marshall R. Absolute quantification of radiotracer uptake in the lungs using a gamma camera. J. Nucl. Med. 23:1982;731-735.
13. Melchor R., Biddiscombe M.F., Mak V.H.F., Short M.D., Spiro S.G. Lung deposition patterns of directly labelled salbutamol in normal subjects and in patients with reversible airflow obstruction. Thorax. 48:1993;506-511.
14. Monaghan P., Provan I., Murray C., Mackey D.W., Van der Wall H., Walker B.M., Jones P.D. An improved radionuclide technique for the detection of altered pulmonary permeability. J. Nucl. Med. 32:1991;1945-1949.
15. NEMA (National Electrical Manufacturers' Association) standard publication No NU1, 1986. Performance measurements of scintillation cameras.
16. ®: a preliminary report. Newman S.P., Morén F., Crompton G.K. A New Concept in Inhalation Therapy. 1987;100-114 Medicom, Bussum, The Netherlands.
17. Newman S., Morén F., Trofast E., Talaee N., Clarke S. Deposition and clinical efficacy of terbutaline sulphate from Turbuhaler, a new multi-dose powder inhaler. Eur. Respir. J. 2:1989;247-252.
18. Newman S., Steed K., Hooper G., Källén A., Borgström L. Comparison of gamma scintigraphy and a pharmacokinetic technique for assessing pulmonary deposition of terbutaline sulphate delivered by pressurized metered dose inhaler. Pharm. Res. 12:1995;231-236.
19. Norrgren, K., Leide-Svegborg, S., Areberg, J., Mattsson, S., 2003. Accuracy of the quantification of organ activity from planar gamma camera images. Cancer Biother. Radiopharm., accepted for publication.
20. Olséni L., Palmer J., Wollmer P. Quantitative evaluation of aerosol deposition pattern in the lung in patients with chronic bronchitis. Physiol. Meas. 15:1994;41-48.
21. Olsson B., Borgström L., Asking L., Bondesson E. Effect of inlet throat on the correlation between measured fine particle dose and lung deposition. Dalby R.N., Byron P.R., Farr S.J. Respiratory Drug Delivery V. 1996;273-281 Interpharm Press, Buffalo Grove, IL.
22. Snell, N.J.C., Ganderton, D., 1999. Assessing lung deposition of inhaled medications. Consensus statement from a workshop of the British Association for Lung Research, held at the Institute of Biology, London, UK on 17 April 1998. Respir. Med., 93, 123-133.